was the talk around the trading desks as the firm was hit with its first nationwide strike in 37 years, and the crew at
"Fast Money" was focused on what it means to the market. Adami has been consistently negative on GM and would rather own
. Macke agrees that GM is a sell, unless they take a huge hit on health care without giving job guarantees.
Online Ad Play
made headlines today as rumors floated around Wall Street that the firm is planning on taking a 5% stake in Facebook.com. Kourosh Karimkhany, manager of wired digital at Conde Naste, joined the crew to discuss who he thinks will win the online ad war.
Karimkhany sees Microsoft's play for Facebook as one for software development. Facebook made its API open to developers and 6000 programs have been created. Facebook is also letting programmers sell ads through their applications and keep the revenue they generate.
Macke says it is time to get long MSFT and the test will be if MSFT doesn't destroy Facebook. Najarian prefers
for the bullish activity he is seeing in the $22.50 and $25 call options.
is another Najarian favorite. Adami picks MSFT to trade at $32. (
Take: Steven Smith said recently, "Microsoft- The two pieces of news fostered generally bullish optimistic option activity, as over three calls traded for every put, but all the volume, even in October 30 call which was the most active strike with 45,000 contracts trading, represented less than 5% of the overall open interest for the October through January options." To read more on what Smith said,
Tuesday will be a big day for
. The software giant will release the hyped up Halo 3 game which is predicted to be the biggest selling game ever.
Aaron Martinez, who runs the video game blog GamersBlock.net, came on the show to discuss his thoughts on the Halo 3. Martinez declares that the game deserves the hype it's getting. He notes that the game has improved on the last two versions and to date it has over 1 million preorders. Macke proposes investors play Halo 3 with trades in
. He advises getting out of
The UBS health care industry conference could help jump start some of the pharmaceutical and biotech stocks this week. With that in mind, Adami suggests
, because he feels the valuation is very cheap on a multiple level. Najarian is impressed with
as a play on preventive medicine. Macke recommends
Johnson & Johnson
Take: Dan Fitzpatrick said recently, "This monthly chart of Johnson & Johnson gives us a good idea of the relatively tight range that has confined the stock. The higher highs and lows are very bullish signals and are likely to lead to yet another breakout. Still, I'd wait for the breakout before buying." To read more on what Fitzpatrick said,
Burning Down the House
The homebuilders sector was annihilated on Monday, as investors fear more bad news is on the way when the government reports existing home sales data Tuesday. Adami advises not to trade this sector unless you have to.
Finerman warns investors to stay away from overlevered firms like
Chartology with Jeff DeGraaf
"Fast Money" is getting technical with a special segment all week called Chartology. On Monday, the crew welcomed technical analysis expert Jeff DeGraaf to the show. DeGraaf likes the looks of the technology sector right now and he thinks it will outperform in the coming months. He feels positive about tech because the sector was strong in the summer when it normally tends to trade down.
DeGraaf looked at
and the chart isn't showing bullish trends. He finds the weakness in the FDX chart troubling because it isn't trading in the same direction as the industrials. To his eyes, this is a yellow flag for the Dow.
Adami doesn't like FDX until it trades above $121 and DeGraaf agreed. DeGraaf loves the pattern in gold and continues to be bullish longer term on the yellow metal. He would look to buy gold on pullbacks.
Word on the Street
lowered same-store sales on Monday. Macke is now concerned about the retail sector. Finerman still likes the retailers but this was bad news for Target, although she believes Target is doing things that could unlock value.
reported an 11% jump in beer volumes on Monday. Macke likes
now more then ever.
The dollar continues to slide as gold trades at 27-year highs. Najarian points out that all the commodity sectors are hot. His favorites are the mining and drilling company
and copper and gold producer
. For Adami, mining stocks are all about M&A, and this means that gold is going lower.
submitted its first application for a new US nuclear reactor in 30 years. Najarian would play this news with
. Billiton traded up 5% on speculation that BHP has discovered the largest gold deposit in the world. Finerman favors
and Adami likes
. Macke would just play
traded higher 8% as solar stocks were active with a major solar conference started. Najarian expects volatility in the solar sector and he likes TSL, which saw heavy call options activity on Monday.
Pops & Drops
traded up 9%. Adami thinks a big short was forced to cover on Monday. He would take profits on CROX.
traded up 2% off a JP Morgan upgrade. Finerman continues to be long this stock and she feels it has more room to run higher.
Las Vegas Sands
traded up 7% off a Jeffries upgrade. Macke says time to get out.
PrimeWest Energy Trust
exploded 32% on news that Abu Dhabi National Energy Co. bought them out. Finerman hopes we keep seeing deals like this.
traded up 8% after Citigroup and Bear Stearns upgraded the name. Adami says this vindication for his call on EMC traded with a 20 handle. He still likes it.
fell 14% after revenue forecasts missed Wall Street expectations. AMR's drop took down all the airline companies for the day.
dropped 6% after the company said profits would miss Wall Street expectations. Finerman wouldn't touch it.
plunged 14% after the telecom company warned on 3rd quarter earnings and revenue. Macke suggests avoiding these guys on the telecom side.
The "Fast Money" team fires away with their best trade ideas for the day.
- Finerman likes NYMEX (NMX) . (RealMoney Take: Steven Smith said recently, "There is also speculation that it might make a play to buy its rival the New York Mercantile Exchange" To read more on what Smith said, click here.)
- Najarian recommends ValueClick (VCLK) .
- Adami advises buying Pfizer (PFE) - Get Pfizer Inc. Report for its cheap valuation.
- Macke declares that the market is going to sell off and he would play it with Short Dow30 ProShares (DOG) - Get ProShares Short Dow30 Report.
Stockpickr is a wholly owned subsidiary of TheStreet.com.